Archives
Press Releases
advertisement
October 27, 2021
- LifeScan launches digital diabetes management platform
- vTv Therapeutics Inc. (NASDAQ: VTVT) Announces Positive TTP399 Mechanistic Study Data on Type 1 Diabetes Patients
- Diabetes Injection Pens Market – Rising incidence of diabetes is expected to propel the demand for insulin injection pens
- New Agreement Places DreaMed Diabetes’s Innovative AI Platform in Leading U.S. Children’s Hospital
- LovedBy and Dexom announce partnership to aid adolescent patients with diabetes
October 20, 2021
October 6, 2021
- Eli Lilly to reduce list price of Insulin Lispro injection by an additional 40% from Jan. 1, restoring it to 2008 levels
- BIOCORP and NOVO NORDISK Sign Global Partnership Within Diabetes on Digital Health. See also Novo Nordisk to smarten up its disposable insulin pens with digital diabetes device maker Biocorp.
- Novo Nordisk settles insulin pricing suit for $100M
- MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population
- Type 1 Diabetes Drug Competitor Analysis Report – Global Forecast to 2026
- JDRF Awards New Grant to Explore Cognitive Behavioral Therapy to Reduce Diabetes Distress
September 29, 2021
- Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency
- Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options
- GLP-1 Receptor Agonist Market: Rise in prevalence of diabetes across globe is expected to drive the market
- Digital Diabetes Management Global Market Report 2021: COVID-19 Growth And Change To 2030
- Type 1 Diabetes Drugs Market Competitive Strategies, Share, & Regional Outlook Forecast up to 2026
September 15, 2021
- $6M NIH Grant Launches UC San Diego Consortium to Study Insulin-Producing Cells
- SNAQ Launches their Diabetes Management App in the US and Adds Leading Experts to the Advisory Board
- Provention Bio Provides Update on the Potential Timing of Teplizumab At-Risk Type 1 Diabetes (T1D) Biologics License Application (BLA) Resubmission
- Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio
advertisement